At the end of the day, GLP-1 isnt something we have to chase
Our study revealed that SGLT2is were associated with a decreased rate of proliferative DR and vitreoretinal interventions compared with GLP1-RAs
Moving Forward and Staying Compliant To adapt, practices should: Monitor the ongoing lawsuit by the Outsourcing Facilities Association (OFA) against the FDA, as it could delay these changes
Data availability Data is provided within the manuscript
Staying consistent matters
Trong cuc sng hng ngy, chng ta tip xc vi nhiu loi ha cht v c t khc nhau thng qua kh thi xe hi, khi thuc l, ru, nhim khng kh, bc x, thuc tr su Khi nhng cht c ny xm nhp vo c th chng ta, chng s bin thnh cht gy ung th v do c th cn phi o thi